Cue Biopharma, Inc.CUENASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank70
3Y CAGR-2.5%
5Y CAGR+28.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-2.5%/yr
vs +8.1%/yr prior
5Y CAGR
+28.1%/yr
Recent deceleration
Acceleration
-10.6pp
Decelerating
Percentile
P70
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $50.51M | -0.6% |
| 2024 | $50.79M | +159.9% |
| 2023 | $19.54M | -64.1% |
| 2022 | $54.47M | -9.9% |
| 2021 | $60.43M | +312.5% |
| 2020 | $14.65M | +15.0% |
| 2019 | $12.74M | -68.0% |
| 2018 | $39.84M | +71.5% |
| 2017 | $23.23M | +203.4% |
| 2016 | $7.66M | - |